Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone Addition to Multimodal Pain Regimens After ACL Reconstruction
NCT07605923Phase 4Not yet recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 2026
- Primary completion
- Aug 2031
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in postoperative pain, sponsored by University of Alabama at Birmingham. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
methylprednisolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07605923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07605923.